All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

/images/Cortellis_Flagship_Logo_TM_RGB_Color.png
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • Diagnosing and tracking COVID-19
    • Drugs to Watch 2020
    • The next pandemic
    • Premium reports
      • BioWorld Financings Reports
      • Disease Forecast Reports

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 12, 2021
Home » Topics » Medical devices and technologies, BioWorld Asia

Medical devices and technologies, BioWorld Asia
%{topic} RSS Feed RSS

WTO addresses vaccine supply, export restrictions

March 16, 2021
By Mari Serebrov
No Comments
With COVID-19 vaccine manufacturing still scaling up and the scarcity of some supplies, most of the vaccine doses available so far have been distributed in 75 countries while 115 countries are still waiting, World Trade Organization Director-General Ngozi Okonjo-Iweala said at the Global C19 Vaccine Supply Chain and Manufacturing Summit.
Read More
Calculator and pills

TGA seeks feedback on impact of proposed fee changes for drugs and devices

Feb. 16, 2021
By Tamra Sami
No Comments
PERTH, Australia – Australia’s Therapeutic Goods Administration is proposing changes to its fees and charges and is asking stakeholders for feedback on three different proposed fee structures for the 2021-2022 financial year.
Read More
China U.S. deal

Many unkept promises, but USTR sees progress in China’s trade commitments

Jan. 26, 2021
By Mari Serebrov
No Comments
When it comes to leveling the playing field for foreign-based biopharma and medical device companies, China has made a lot of promises, but delivering on those promises is what matters.
Read More
OTX-TIC

Ocular and Affamed strike a $103M deal to develop Dextenza in Asia

Nov. 3, 2020
By Lee Landenberger
No Comments
Ocular Therapeutix Inc. and Affamed Therapeutics Ltd. entered a license and collaboration agreement to develop and commercialize Dextenza and OTX-TIC in greater China, South Korea and the Association of Southeast Asian Nations markets.
Read More
Asia at night from space
BIO Asia-Taiwan 2020

Boosted by COVID-19 success, Taiwan life sciences sector building government, investor support

July 28, 2020
By Elise Mak
No Comments
With no new cases reported for more than 100 days, Taiwan appears to have successfully contained the spread of COVID-19 and has drawn attention to its medical achievements.
Read More
U.S., China wrecking balls

Hacking indictment details decade of thefts, ramps up U.S.-China tensions

July 28, 2020
By Mari Serebrov
No Comments
The alleged activities of two Chinese hackers outlined in a federal indictment unsealed Tuesday offer “concrete examples of two concerning trends,” U.S. Assistant Attorney General John Demers said, as U.S.-China relations further soured with the news of the charges.
Read More
Approved stamp

Zai Lab and Novocure score the first China approval for glioblastoma in 15 years

May 19, 2020
By David Ho
No Comments
HONG KONG –Shanghai-based Zai Lab Ltd. has won an approval for the first innovative treatment for glioblastoma approved by China in more than 15 years, with the National Medical Products Administration’s nod for Optune in combination with temozolomide for use in patients with newly diagnosed glioblastoma.
Read More
U.S. flag on columned building

2020 Special 301 report calls out the usual U.S. trade partners for IP offenses

May 5, 2020
By Mari Serebrov
No Comments
Saudi Arabia, which last year made its first appearance on the U.S. Trade Representative’s (USTR) Priority Watch List, is back on the list this year and is being singled out for an out-of-cycle review due to what the USTR calls its “unfair commercial use” and “unauthorized disclosure” of proprietary data submitted for drug approvals.
Read More
U.S.-China money

Industry: Trade agreement important first step toward fairer Chinese market

Jan. 21, 2020
By Mari Serebrov
No Comments

Time will tell whether what the Trump administration is calling a “historic” and “landmark” trade agreement with China will better enable drug and device companies to more fairly compete in the Chinese market without having to sacrifice their intellectual property (IP) and technology.


Read More

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 9.
  • IPO puzzle pieces

    Somalogic to merge with CM Life Sciences II SPAC, as trendy IPO path continues

    BioWorld MedTech
    Somalogic Inc. has agreed to go public via a merger with blank-check company CM Life Sciences II. Upon closing, CMLS II – a special purpose acquisition company...
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for April 9.
  • Earth threatened by virus

    Global cases rise, but more weapons advance to combat COVID-19

    BioWorld
    As COVID-19 vaccinations continue to roll out, momentum builds with strong phase III data for what could become the fourth and fifth walls of defense in the U.S.
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • About
    • Archives
    • Today's news
    • Search BioWorld Science
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
A Clarivate Analytic solution. Link to Clarivate website.
Follow Us

Copyright ©2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing